Methenamine Pregnancy and Breastfeeding Warnings
Methenamine is also known as: Hiprex, Mandelamine, Urex
Methenamine Pregnancy Warnings
Methenamine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. It is known to cross the placenta. Two studies of methenamine use during pregnancy have not reported an increase adverse fetal outcome when compared to controls. Methenamine should only be given during pregnancy when benefit outweighs risk.
The Collaborative Perinatal Project reported 49 pregnancies involving first-trimester exposure to methenamine. Birth defects were reported in 4 infants. In 299 pregnancies involving exposure to methenamine anytime during pregnancy, 12 malformations were reported (5.34 expected). In a review of 229,101 deliveries to Michigan Medicaid patients, 209 first-trimester exposures to methenamine were recorded and 778 exposures anytime during pregnancy. A total of 8 birth defects were reported with first-trimester exposure (8 expected) and included (observed/expected) one cardiovascular defect, one oral clefts, one polydactyly, and one limb reduction.
Methenamine Breastfeeding Warnings
Methenamine is excreted into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
See Also...
- Methenamine use while Breastfeeding (in more detail)
- Methenamine Hippurate use while Breastfeeding (in more detail)
- Methenamine Mandelate use while Breastfeeding (in more detail)
- methenamine Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
